Literature DB >> 20163027

[A case of intravascular lymphoma with diffuse centrilobular opacities].

Hiromi Shinoda1, Arafumi Maejima, Kumi Shimizu, Akio Onaka, Taigen Boku, Yoshitaka Oyamada.   

Abstract

A 54-year-old woman was admitted with general fatigue and dyspnea on exertion. Her serum LDH level was markedly elevated to 2145 IU/L, and chest CT revealed diffuse centrilobular opacities. Total cell counts in bronchoalveolar lavage fluid were elevated, and lymphocytes accounted for 98% of the cells. A transbronchial lung biopsy demonstrated numerous CD20-positive atypical cells in the alveolar capillaries, so intravascular lymphoma (IVL) was diagnosed as having. Lymphoma cells were also present in the bone marrow sinusoids, while there was no sign of hemophagocytosis. Combined chemotherapy (CHOP with rituximab) successfully induced complete remission, and she has been free of recurrence for 40 months. In cases with diffuse centrilobular opacities on chest CT, accompanied by elevated serum LDH, it is important to rule out IVL by performing TBLB.

Entities:  

Mesh:

Year:  2010        PMID: 20163027

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  2 in total

1.  Lung intravascular large B-cell lymphoma with ground glass opacities on chest computed tomography: a case report.

Authors:  Desheng Xiao; Chunyan Fu; Xueying Long; Wei Liu; Chen Chen; Jianhua Zhou; Songqing Fan
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

2.  Treatment strategy for reducing the risk of rituximab-induced cytokine release syndrome in patients with intravascular large B-cell lymphoma: a case report and review of the literature.

Authors:  Katsuhiro Makino; Jumi Nakata; Satoru Kawachi; Tatsuyuki Hayashi; Atsuo Nakajima; Munehiro Yokoyama
Journal:  J Med Case Rep       Date:  2013-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.